These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1405777)

  • 1. Prognostic features in patients with congestive heart failure and selection criteria for cardiac transplantation.
    Edwards BS; Rodeheffer RJ
    Mayo Clin Proc; 1992 May; 67(5):485-92. PubMed ID: 1405777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recipient selection and management before cardiac transplantation.
    Frantz RP; Olson LJ
    Am J Med Sci; 1997 Sep; 314(3):139-52. PubMed ID: 9298040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of atrial natriuretic peptide at peak exercise: a prognostic marker of cardiovascular-related death and heart transplantation in patients with moderate congestive heart failure.
    de Groote P; Millaire A; Pigny P; Nugue O; Racadot A; Ducloux G
    J Heart Lung Transplant; 1997 Sep; 16(9):956-63. PubMed ID: 9322147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pre-transplant evaluation: which patients for the active list?].
    Soares RM
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():59-65. PubMed ID: 11409075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of cardiac pumping capacity during exercise predicts prognosis in patients with congestive heart failure.
    Scharf C; Merz T; Kiowski W; Oechslin E; Schalcher C; Brunner-La Rocca HP
    Chest; 2002 Oct; 122(4):1333-9. PubMed ID: 12377861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
    Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
    Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
    Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
    de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
    Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.
    Lund LH; Aaronson KD; Mancini DM
    Am J Cardiol; 2005 Mar; 95(6):734-41. PubMed ID: 15757599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic patterns, clinical evaluation, and long-term prognosis in chronic congestive heart failure.
    Franciosa JA
    Am J Med; 1986 Feb; 80(2B):14-21. PubMed ID: 3946464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption.
    Cattadori G; Agostoni P; Corrà U; Di Lenarda A; Sinagra G; Veglia F; Salvioni E; La Gioia R; Scardovi AB; Emdin M; Metra M; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Mezzani A; Scrutinio D; Pacileo G; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Giannuzzi P; Battaia E; Cicoira M; Passino C; Piepoli MF;
    Int J Cardiol; 2013 Oct; 168(5):5078-81. PubMed ID: 23962781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Congenital heart disease and acquired valvular lesions in pregnancy].
    Horstkotte D; Fassbender D; Piper C
    Herz; 2003 May; 28(3):227-39. PubMed ID: 12756480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
    Levine TB; Levine AB; Goldberg D; Narins B; Goldstein S; Lesch M
    J Heart Lung Transplant; 1996 Mar; 15(3):297-303. PubMed ID: 8777214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up.
    Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure.
    Cohen-Solal A; Tabet JY; Logeart D; Bourgoin P; Tokmakova M; Dahan M
    Eur Heart J; 2002 May; 23(10):806-14. PubMed ID: 12009721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and selection criteria for cardiac transplantation.
    Lösse B
    Thorac Cardiovasc Surg; 1990 Oct; 38(5):276-9. PubMed ID: 2264035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation an answer for end-stage heart failure.
    Smith L; Farroni J; Baillie BR; Haynes H
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):489-94. PubMed ID: 14717394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.